Home / BlackRock and iShares / iSHARES TRUST / iShares Biotechnology ETF
iShares Biotechnology ETF
A series of iSHARES TRUST
- Vote records
- 1,813year to 30 June 2026
- Against management
- 7.8%141 of 1,802 marked votes
- Say-on-pay support
- 91.6%for, of for + against + abstain
- Shareholder-proposal support
- 0.0%for, of for + against + abstain
iShares Biotechnology ETF is a series of iSHARES TRUST. For the year to 30 June 2026 its registrant reported 1,813 vote records for the series; 7.8% of the votes marked for or against management went against management. It voted for 91.6% of say-on-pay items and for 0.0% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2026 | This series | Its registrant | BlackRock and iShares | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 7.8% | 6.7% | 7.5% | 6.2% |
| Say-on-pay support rate | 91.6% | 91.0% | 88.3% | 91.6% |
| Shareholder-proposal support rate | 0.0% | 12.1% | 11.9% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 995 | 912 | 23 | 8.2% | |
| SECTION 14A SAY-ON-PAY VOTES | 235 | 189 | 19 | 8.5% | |
| AUDIT-RELATED | 255 | 255 | 0 | 0.0% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 9 | 7 | 2 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 13 | 13 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 87 | 79 | 8 | 9.4% | |
| COMPENSATION | 143 | 123 | 19 | 17.0% | |
| CORPORATE GOVERNANCE | 95 | 82 | 12 | 7.9% | |
| ENVIRONMENT OR CLIMATE | 1 | 1 | 0 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 1 | 0 | 1 | 0.0% | |
| OTHER SOCIAL ISSUES | 3 | 2 | 1 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2024 | 1,621 | 11.0% | 90.9% | 11.1% |
| year to 30 June 2025 | 3,556 | 8.7% | 89.9% | 11.1% |
| year to 30 June 2026 | 1,813 | 7.8% | 91.6% | 0.0% |
Questions
How often did iShares Biotechnology ETF vote against management?
7.8% of the votes its registrant marked for or against management in the year to 30 June 2026 (141 of 1,802).
How did iShares Biotechnology ETF vote on executive pay?
It voted for 186 of 203 say-on-pay items cast for, against or abstain (91.6%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by iSHARES TRUST, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by iSHARES TRUST (filer no. 1100663); votes attributed to series S000004350 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.